OncoMatch/Clinical Trials/NCT07865117
Development of a Digital Personalised Nutrition Tool for Adolescents Undergoing Cancer Treatment
Official title: Digital Innovation for Personalised Nutrition in Adolescent Oncology
Is NCT07865117 recruiting? Yes, currently enrolling (Oct 2026). This NA trial studies non-drug interventions for paediatric oncology.
This study aims to develop and test MybYte, a smartphone tool designed to support personalised nutrition for teenagers aged 12-18 undergoing cancer treatment. MybYte will ask short questions about eating, appetite and treatment-related symptoms and provide personalised nutrition advice developed by healthcare professionals. In Phase 1, around 15 teenagers will help co-design and refine the tool through interviews and feedback. In Phase 2, around 15 newly diagnosed teenagers will use MybYte for one week each month over six months, alongside routine assessments of nutrition, body composition, taste, energy needs and quality of life. The study will assess whether MybYte is acceptable, practical and helpful for teenagers receiving cancer treatment.
Check if I qualifyEligibility summary
For patients with Pediatric Oncology.
This summary was generated by AI from the trial's official eligibility criteria and may contain errors. Always confirm with the study team before contacting a site.
Frequently asked questions
Is NCT07865117 currently recruiting?
Yes, this trial is currently recruiting patients.
Is there an age limit?
Yes. Patients must be 18 years or younger and at least 12 years old.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify